Healthcare services provider McKesson (NYSE:MCK) has agreed to acquire prescription price transparency and benefit analytics provider Rx Savings Solutions in a deal valued at $875 million.
This includes an upfront payment of $600 million and a maximum contingent payment of $275 million.
The move boosts MCK’s position in access and affordability while also laying the groundwork for an expansion of adherence, outcome management as well as biopharma (evidence-based), and payer services for the company.
Read full Disclosure